Wearable Health Sensor Patents

Wearable health sensor patents cover optical photoplethysmography (PPG) innovations; electrocardiogram (ECG) and bioimpedance innovations; motion-artifact and signal-processing innovations; and FDA-cleared health-algorithm innovations — with IP held by smartwatch makers, ring/band specialists, and medical-sensor companies. MAJOR WEARABLE-SENSOR PATENT HOLDERS: APPLE (Apple Watch, large estate): PPG optical heart-rate (green and infrared LEDs + photodiodes), single-lead ECG (electrodes on crown and back crystal), blood-oxygen SpO2 (red/IR reflectance pulse oximetry), irregular-rhythm/AFib notification, wrist temperature for cycle tracking, and crash/fall detection. FITBIT / GOOGLE (large estate): PPG heart-rate and heart-rate variability HRV, SpO2, EDA electrodermal-activity stress sensing, sleep staging, and activity tracking. SAMSUNG: Galaxy Watch BioActive sensor combining PPG + ECG + BIA bioelectrical-impedance-analysis (body composition) in one module. OTHERS: Garmin (multi-sport optical HR, Pulse Ox), Oura (smart ring — PPG, skin temperature, sleep/readiness), Whoop (strap — continuous HR/HRV/strain/recovery), Withings, Masimo and Medtronic (clinical pulse oximetry and continuous monitoring — Masimo's pulse-ox patents drove the Apple Watch ITC import dispute), Polar, and Dexcom/Abbott on the CGM side.

Photoplethysmography optical-architecture innovations; electrocardiogram electrode and acquisition innovations; bioimpedance and multi-modal sensing innovations; and other physiological-sensing innovations represent core wearable-sensor patent domains. PPG / OPTICAL PATENTS: LED wavelength selection and multi-wavelength (green for HR on the wrist, red+IR for SpO2), LED/photodiode geometry and count, light-pipe and optical-isolation design to reduce ambient-light and skin-contact artifact, reflectance vs. transmission pulse oximetry, and perfusion-index measurement. ECG PATENTS: dry-electrode placement (case back + digital crown closing a single-lead loop), low-noise analog front end, lead-off detection, and on-device rhythm classification. BIOIMPEDANCE PATENTS: BIA electrode design and frequency for body composition, hydration, and respiration; impedance-based contact and fit detection. OTHER-SENSOR PATENTS: skin/wrist temperature sensing (cycle prediction, fever, baseline deviation), electrodermal activity EDA for stress, accelerometer/gyroscope IMU for activity/sleep/fall, and emerging non-invasive optical sensing (Raman/spectroscopy attempts at glucose, blood pressure via pulse transit time / PPG morphology, hydration). Optical sensor architecture and motion-robust acquisition are the most fought-over wearable IP because they determine accuracy on a moving wrist.

Motion-artifact-removal innovations; physiological-algorithm innovations; FDA-cleared health-feature innovations; and power/form-factor innovations represent additional wearable-sensor patent domains — though pure-algorithm claims face §101 scrutiny and are often paired with sensor hardware. SIGNAL-PROCESSING PATENTS: motion-artifact compensation (accelerometer-aided adaptive filtering, source separation to remove cadence harmonics from PPG during exercise), ambient-light rejection, signal-quality assessment, and sensor-fusion across PPG/IMU/ECG. ALGORITHM PATENTS: AFib/arrhythmia detection from PPG/ECG, sleep-stage classification, VO2max and fitness estimation, HRV-based stress/recovery, respiratory-rate, blood-pressure estimation, and overnight SpO2/sleep-apnea screening — these are frequently claimed together with the specific sensor and on-device implementation to survive Alice/§101 (a pure 'detect AFib with a neural network' claim is abstract-idea-vulnerable). REGULATORY-LINKED PATENTS: FDA De Novo / 510(k)-cleared features (ECG app, irregular-rhythm notification, AFib history) where the clearance itself is a competitive moat alongside the IP. POWER / FORM-FACTOR PATENTS: ultra-low-power sensing duty-cycling, battery and charging, ring/band ergonomics and skin-contact stability, and water resistance. Clearance + accuracy data + the sensor-plus-algorithm combination is what actually differentiates and defends a wearable health feature.

Wearable health sensor startup IP strategy must navigate Apple's deep Apple Watch sensor and algorithm estate, Fitbit/Google and Samsung multi-modal sensor patents, Masimo/Medtronic clinical pulse-oximetry patents (which produced the Apple Watch ITC import ban — a vivid lesson that medical-sensor incumbents will enforce), and a §101-constrained landscape where pure-algorithm health claims are weak; understand that the durable IP is the specific optical-sensor architecture plus motion-robust acquisition (hardware), that pure detection algorithms must be tied to sensor hardware to survive Alice, and that FDA clearance is a parallel moat as important as patents; identify whitespace in novel non-invasive sensing (cuffless blood pressure, optical glucose/hydration), motion-robust multi-wavelength PPG, low-power continuous sensing, and ring/patch form factors. WEARABLE-SENSOR STARTUP IP STRATEGY: SENSOR ARCHITECTURE IS THE IP, ALGORITHMS MUST BE TIED TO HARDWARE: patent the specific optical geometry, multi-wavelength LED/photodiode layout, and motion-robust acquisition; a pure 'detect condition X with ML' claim is §101-weak — claim the sensor-plus-method as an integrated technical system; RESPECT THE CLINICAL-SENSOR INCUMBENTS: Masimo's pulse-ox patents banned Apple Watch blood-oxygen at the ITC — clear FTO against medical pulse-oximetry/monitoring patents before shipping SpO2 or BP features; NOVEL NON-INVASIVE SENSING IS HIGHEST-VALUE WHITESPACE: cuffless blood pressure (PPG morphology / pulse transit time), optical/Raman glucose, and hydration are the commercial prizes and least-consolidated terrain; FDA CLEARANCE IS A PARALLEL MOAT: De Novo/510(k) for an ECG or AFib feature gates competitors as much as IP — pursue both; WHEN TO PATENT: NOVEL SENSOR/FEATURE WITH MEASURED ACCURACY: file once a sensor+algorithm shows measured accuracy (sensitivity/specificity vs. clinical reference, MAE on a moving wrist, agreement vs. gold standard) — measured accuracy, motion-robustness, power draw, and clinical agreement are the critical wearable IP metrics; KEY FTO CHECKLIST: Apple PPG green/IR optical HR, crown/back single-lead ECG, red/IR SpO2, irregular-rhythm AFib, wrist temperature; Fitbit/Google HRV EDA sleep; Samsung BioActive PPG+ECG+BIA; Masimo/Medtronic reflectance pulse oximetry (ITC); motion-artifact accelerometer adaptive filtering; cuffless BP pulse-transit-time; Alice/§101 limits on pure-algorithm detection; FDA De Novo/510(k) clearance.